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Abstract. 
 
During neuromuscular junction formation, 
agrin secreted from motor neurons causes muscle cell 
surface acetylcholine receptors (AChRs) to cluster at 
synaptic sites by mechanisms that are insufﬁciently un-
derstood. The Rho family of small guanosine triphos-
phatases (GTPases), including Rac and Cdc42, can
mediate focal reorganization of the cell periphery in
response to extracellular signals. Here, we investigated 
the role of Rac and Cdc42 in coupling agrin signaling to 
AChR clustering. We found that agrin causes marked 
muscle-speciﬁc activation of Rac and Cdc42 in differen-
tiated myotubes, as detected by biochemical measure-
ments. Moreover, this activation is crucial for AChR 
clustering, since the expression of dominant interfering 
mutants of either Rac or Cdc42 in myotubes blocks 
agrin-induced AChR clustering. In contrast, constitu-
tively active Rac and Cdc42 mutants cause AChR to
aggregate in the absence of agrin. By indicating that 
agrin-dependent activation of Rac and Cdc42 consti-
tutes a critical step in the signaling pathway leading to 
AChR clustering, these ﬁndings suggest a novel role for 
these Rho-GTPases: the coupling of neuronal signaling 
to a key step in neuromuscular synaptogenesis.
Key words: nicotinic acetylcholine receptors • neuro-
muscular junction • guanosine triphosphate–binding 
proteins • Rac • Cdc42
 
Introduction
 
Acetylcholine receptors (AChRs)
 
1
 
 that are diffusely dis-
tributed on the surface of cultured C2C12 muscle cells be-
come aggregated into clusters upon treatment with neural
agrin (Bowen et al., 1996; Ferns et al., 1996). This mimics
the action of agrin secreted by motor neurons during the
formation of neuromuscular junctions (Bowe and Fallon,
1995; Burden, 1998; Sanes and Lichtman, 1999). There is
evidence that agrin initiates its effects by binding to a sur-
face complex comprised of a recently characterized mus-
cle-specific receptor tyrosine kinase (MuSK), and other as
yet unidentified muscle surface components (DeChiara et al.,
1996). The clustering of AChRs is accompanied by in-
creased anchorage of these receptors to the cytoskeletal
framework and loss of lateral mobility (Prives et al., 1982;
Stya and Axelrod, 1983). Furthermore, agrin induces the
coclustering with AChR of other synaptic proteins, includ-
ing the actin-binding cytoskeletal proteins utrophin and
 
a
 
-actinin (Shadiack and Nitkin, 1991; Apel et al., 1997).
These findings support the possibility that the clustering of
AChR and other cell surface components can be mediated
through agrin-induced cytoskeletal reorganization (Hoch
et al., 1994).
Members of the Rho family of small GTPases, including
Rac and Cdc42, have been shown to mediate focal reorga-
nization of the actin cytoskeleton in response to extracel-
lular cues in several cell types (Burridge and Chrza-
nowska-Wodnicka, 1996; Tapon and Hall, 1997; Hall,
1998). The activation of Rac by membrane signaling is
known to produce actin reorganization at the cell periph-
ery, giving rise to lamellipodia and membrane ruffles
(Tapon and Hall, 1997; Hall, 1998). Cdc42 activation leads
to the formation of actin-containing filopodia (Tapon and
Hall, 1997) as well as to Rac activation (Keely et al., 1997).
There is now considerable evidence that Rac and Cdc42
produce changes in cytoskeletal organization by control-
ling actin polymerization via multiple regulatory pathways
(Arber et al., 1998; Yang et al., 1998; Sells et al., 1999; Van
Leeuwen et al., 1999). Based on the demonstrated ability
in other cell types of Rac/Cdc42 to link the signaling of
surface receptors for growth factors to localized actin po-
lymerization at the cell periphery (Hall, 1998), we have in-
vestigated the contribution of these small G proteins to
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the Cdc42/Rac (p-21)–binding domain; JNK, c-Jun NH
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a
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agrin-induced AChR clustering in muscle cells. We show
that agrin triggers the activation of Rac and Cdc42, and
present evidence that this activation is crucial for agrin-
induced AChR clustering. Moreover, like other actions of
agrin, the stimulation of Rac and Cdc42 was not observed
with nonmuscle cells.
 
Materials and Methods
 
Reagents and Cell Culture
 
Soluble recombinant neural agrin was prepared from COS cells with
cDNA encoding the COOH-terminal half of agrin (Ferns et al., 1993), and
concentrations were determined in comparison to purified agrin by West-
ern blotting.
Expression plasmids encoding T7 epitope-tagged constitutively active
Rac (RacV12), dominant interfering Rac (RacN17), myc epitope–tagged
constitutively active Cdc42 (Cdc42V12), and dominant interfering Cdc42
(Cdc42N17) were provided by D. Bar-Sagi (State University of New York
at Stony Brook). A plasmid-encoding GST fused to the Cdc42/Rac
(p-21)–binding domain (GST-PBD) was a gift from S. Moores and J.
Brugge (Harvard University, Cambridge, MA).
C2C12 mouse muscle cells were plated on 12-mm-diameter glass cover-
slips in 35-mm culture dishes for microscopy or in 100-mm culture dishes
for kinase assays. The cells were cultured at 37
 
8
 
C with 5% CO
 
2
 
 in growth
medium consisting of DME supplemented with 10% (vol/vol) fetal bovine
serum and 5% (vol/vol) calf serum (Life Technologies). 2 d after plating,
when the cells reached 50–70% confluence, the growth medium was re-
placed with differentiation medium consisting of DME containing 2%
(vol/vol) horse serum (Life Technologies). During the subsequent 1.5–2 d,
a major proportion of the C2C12 myoblasts fused to form multinucleated
myotubes. At this stage, myotube cultures were treated with 5 nM agrin
where specified.
 
Transfection
 
24 h after plating, C2C12 myoblast cultures were transfected with plas-
mids encoding one of the following: RacV12, RacN17, Cdc42V12,
Cdc42N17, or RasN17 at a final concentration of 5 
 
m
 
g of DNA per ml, us-
ing either calcium phosphate precipitation or LipofectAMINE reagent
(Life Technologies). After 16 h of incubation, the transfection medium
was replaced with differentiation medium.
 
Cell Staining
 
To visualize the surface distribution of AChR, myotube cultures after 48 h
in differentiation medium were incubated with 10 nM TMR-
 
a
 
-bungaro-
toxin (TMR-Bgt; Molecular Probes) in DME with 1 mg/ml BSA for 1 h at
37
 
8
 
C, rinsed with PBS, and fixed with 3.7% formaldehyde/PBS for 30 min
at room temperature. To detect expression of exogenous Rac, Cdc42, or
Ras mutants, the fixed cells were permeabilized with 0.2% Triton X-100/
PBS, and then blocked with 10 mg/ml BSA in PBS. The coverslips were
incubated with anti-T7 antibody (Novagen) or anti-myc antibody (Santa
Cruz Biotechnology, Inc.) for 1 h at 37
 
8
 
C, rinsed with PBS, and stained by
incubating with an FITC-conjugated goat anti–mouse antibody (Cappel)
for 1 h at 37
 
8
 
C. Coverslips were mounted on slides using Aqua-Mount
(Lerner Laboratories). Images were acquired using an Axiophot fluores-
cence microscope (ZEISS).
 
Rac and Cdc42 Activity Assay
 
C2C12 mouse muscle myoblasts and myotubes were treated with 5 nM
agrin for 15 min and then rinsed with ice-cold PBS supplemented with 1 mM
MgCl
 
2
 
 and 0.5 mM CaCl
 
2
 
. Cells were then incubated for 5 min on ice with
lysis buffer (50 mM Tris-HCl, pH 7.4, 10 mM MgCl
 
2
 
, 1% NP-40, 10% glyc-
erol, 100 mM NaCl, 1 mM benzamidine, 1 
 
m
 
g/ml leupeptin, 1 
 
m
 
g/ml pep-
statin, 1 
 
m
 
g/ml aprotinin, and 0.5% sodium deoxycholate), and were cen-
trifuged for 5 min at 21,000 
 
g
 
 at 4
 
8
 
C. The supernatants were then
incubated with bacterially produced GST fused to the Cdc42/Rac (p-21)–
binding domain of PAK (GST-PBD) fusion protein bound to glutathione-
coupled sepharose beads (Sander et al., 1998) for 30 min at 4
 
8
 
C. The fu-
sion protein beads with bound proteins were then washed three times in
an excess of lysis buffer, eluted in Laemmli sample buffer (Laemmli,
 
1970), and then analyzed by Western blotting with either a mouse mono-
clonal antibody against human Rac1 (Transduction Laboratories) or a
polyclonal antibody against the human Cdc42 COOH-terminal 22–amino
acid peptide (kindly provided by R. Cerione, Cornell University, Ithaca,
NY), at a 1:1,000 dilution. Blots were developed using goat anti–mouse
(for Rac1) or goat anti–rabbit (for Cdc42) coupled to horseradish per-
oxidase (1:10,000 dilution) and visualized with the enhanced chemilumi-
nescence (ECL) detection system (Amersham Pharmacia Biotech).
 
Kinase Assays
 
To assay for c-Jun NH
 
2
 
-terminal kinase (JNK), C2C12 myotubes were
treated with 5 nM agrin in DME at 37
 
8
 
C for the specified intervals. JNK
was pulled down using a GST–c-Jun fusion protein (Tan et al., 1996). The
cells were washed with ice-cold PBS, lysed with 1.0 ml of lysis buffer (20 mM
Tris, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1% Triton
X-100; 2.5 mM sodium pyrophosphate; 1 mM 
 
b
 
-glycerophosphate; 1 mM
Na
 
3
 
VO
 
4
 
; 1 
 
m
 
g/ml leupeptin; and 1 mM PMSF) and incubated with 2 
 
m
 
g of
GST–c-Jun fusion protein beads (New England Biolabs, Inc.) at 4
 
8
 
C over-
night. The beads were washed twice each with lysis buffer and kinase
buffer (25 mM Tris, pH 7.5; 5 mM 
 
b
 
-glycerophosphate; 2 mM DTT; 0.1 mM
Na
 
3
 
VO
 
4
 
; and 1 
 
m
 
g/ml leupeptin). The JNK activity present in the immuno-
precipitate was determined by resuspension in 50 
 
m
 
l of kinase buffer sup-
plemented with 100 
 
m
 
M ATP. After 30 min at 30
 
8
 
C, the reactions were
terminated by adding 25 
 
m
 
l of 3
 
3
 
 sample buffer. The proteins were re-
solved by SDS-PAGE on 10% acrylamide gels and then transferred to ni-
trocellulose by Western blotting. The membranes were immunoblotted
with antiphospho c-Jun (Ser63) antibody (New England Biolabs, Inc.).
Immunocomplexes were visualized by ECL, and signals were quantitated
using a Bio-Rad Laboratories imaging densitometer with Molecular Ana-
lyst software.
For the JNK assays using Rac and Cdc42 transfected cells, C2C12 cells
were cotransfected using LipofectAMINE reagent (Life Technologies)
with FLAG epitope–tagged JNK1 and RacV12, RacN17, Cdc42V12, or
Cdc42N17. After 2 d in differentiation medium, the C2C12 cells were
treated with 5 nM agrin in DME at 37
 
8
 
C for varying amounts of time. The
cells were then harvested and the transfected JNK was immunoprecipi-
tated as previously described (Nimnual et al., 1998). The immunocom-
plexes were incubated in 50 
 
m
 
l of kinase buffer containing 10 
 
m
 
Ci of
 
g
 
-[
 
32
 
P]ATP (7,000 Ci/mmol) (ICN Biomedicals) and 3 
 
m
 
g GST–c-Jun as a
substrate. After 30 min at 30
 
8
 
C, the reactions were terminated with 5
 
3
 
sample buffer. After fractionation by SDS-PAGE, GST–c-Jun phosphory-
lation was measured by autoradiography and quantitated using a Phos-
phorImager (Molecular Dynamics). Background levels of Rac or Cdc42
and JNK expression were determined by Western blotting and incubation
with anti-JNK1, anti-T7, or anti-myc (Santa Cruz Biotechnology, Inc.) pri-
mary antibodies. Immunocomplexes were visualized by ECL.
 
Results
 
Dominant Interfering Mutants of Rac and Cdc42 
Prevent Agrin-induced AChR Clustering
 
Under the culture conditions used here, AChR clusters,
as visualized by fluorescence microscopy of myotubes
surface-labeled with the rhodamine-tagged AChR ligand
TMR-Bgt, were rarely seen in agrin-untreated cultures but
were prominent in agrin-treated cells (Fig. 1 A, panels a
and b). Agrin-induced AChR clustering was clearly visible
by 4 h of exposure and was maximal by 6 h. The crucial
role of actin-based cytoskeleton in the formation of these
AChR clusters is shown by the effect of the actin-disrupt-
ing toxin latrunculin B (Spector et al., 1989) on agrin-
dependent AChR surface redistribution. AChR clustering
induced by a 6-h exposure of myotubes to agrin (Fig. 1 A,
panel b) was blocked in the presence of 0.2 
 
m
 
M latrunculin
B (Fig. 1 A, panel c).
To determine the roles of Rac and Cdc42 in agrin-
induced AChR clustering, C2C12 myoblasts were trans-
fected with dominant interfering (N17, GDP-bound) mu- 
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tants of Rac and Cdc42, and muscle differentiation was
subsequently induced by switching the cultures from
growth medium to differentiation medium, as described in
Materials and Methods. 3 d after transfection, the effects
of these mutants on AChR surface distribution in agrin-
treated and -untreated myotubes were examined by fluo-
rescence microscopy of TMR-Bgt–labeled cells. In con-
trast to the agrin-induced AChR clustering seen in cells
transfected with vector only (Fig. 1 B, a and b), myotubes
expressing RacN17 (Fig. 2 A, a and b) or Cdc42N17 (Fig. 2
A, c and d) did not display AChR clustering after identical
agrin treatment, or even at agrin concentrations 30-fold
higher than required for maximal clustering in control
myotubes (data not shown).
The inhibition of agrin-induced AChR clustering is not
a general characteristic of dominant interfering mutants of
small G proteins, as indicated by the observation that
RasN17, a dominant interfering mutant Ras, did not block
agrin-induced AChR aggregation (Fig. 2 A, e and f).
Moreover, the differentiation of muscle cells expressing
RacN17 and Cdc42N17 was not impaired, as was evi-
denced by their ability to undergo fusion (Fig. 2 A, a–d)
and to display surface AChR at levels comparable to non-
transfected myotubes (Fig. 2 A, b and d). Furthermore,
these transfected myotubes were indistinguishable from
mock-transfected and nontransfected myotubes in expres-
sion of muscle contractile proteins, including sarcomeric
actin (Fig. 1 B, c and d) and myosin (data not shown), as
detected by immunostaining.
Quantitative comparison of the number of AChR clus-
ters on the surface of myotubes expressing either RacN17
or Cdc42N17 mutants versus control myotubes showed a
Figure 1. Prevention of
agrin-induced AChR cluster-
ing by inhibition of actin po-
lymerization. (A) AChRs,
stained with TMR-Bgt, are
uniformly dispersed on un-
treated control C2C12 myo-
tubes (a). In contrast, myo-
tubes treated with agrin (5
nM, 6 h) show extensive
AChR clustering (b; arrows).
This effect is prevented by la-
trunculin B (0.2 mM), which
interferes with actin polymer-
ization (c). (B) C2C12 cul-
tures were transfected with
T7 epitope–tagged vector or
RacN17, or Myc-tagged
Cdc42N17. After 2 d in differ-
entiation medium, cultures
were examined by fluores-
cence microscopy. Vector-
transfected C2C12 muscle
cells (a) show AChR cluster-
ing (arrows) in response to
agrin (16 h; b). Expression of
RacN17 (c) does not interfere
with myoblast fusion and ex-
pression of sarcomeric actin in
myotubes (d). Bars, 10 mm. 
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.
 
90% inhibition of agrin-induced AChR clustering by the
dominant interfering mutants of both Rac and Cdc42 (Fig.
2 B). These findings indicate that Rac and Cdc42 activa-
tion is necessary for agrin-induced AChR clustering.
 
Constitutively Active Rac and Cdc42 Mutants Induce 
AChR Aggregation
 
To determine whether activation of Rac or Cdc42 is in it-
self sufficient to produce AChR aggregation, cells were
transfected with the constitutively active mutants RacV12
or Cdc42V12 and the effects on AChR surface distribution
were examined in agrin-untreated myotubes. Under these
conditions, we found that the expression of either RacV12
or Cdc42V12 produced AChR aggregation (Fig. 3), par-
tially mimicking the effect of agrin. However, although
agrin treatment resulted in the formation of large AChR
clusters (Fig. 1 A, b), RacV12 and Cdc42V12 induced the
appearance of small, punctate AChR aggregates (1–5-
 
m
 
m-
diameter), referred to here as microclusters (Fig. 3 A, b
and d). The induction of microclusters by both mutants is
also evident from a quantitative comparison of the num-
ber of AChR microclusters on the surface of myotubes ex-
pressing either RacV12 or Cdc42V12 versus control myo-
tubes (Fig. 3 B). Thus, it appears that activation of Rac
and Cdc42 is sufficient for microcluster formation in agrin-
untreated myotubes, but is insufficient for the aggregation
of microclusters into full-sized clusters.
 
Agrin Treatment Causes Activation of Rac and Cdc42 
in Myotubes
 
To determine whether Rac and Cdc42 are directly in-
volved in agrin-induced AChR clustering, we examined
the effects of agrin on Rac and Cdc42 activity.
 
 
 
As shown in
Fig. 4 A, exposure of intact myotubes to agrin caused
strong activation of Rac as well as of Cdc42, as measured
in cell lysates by the selective binding of the activated
forms of Rac (Fig. 4 A, a) and Cdc42 (Fig. 4 A, b) to
GST-PBD, a GST fusion protein containing the Rac/
Cdc42-binding domain of PAK (Sander et al., 1998). In
addition, we used the JNK signaling cascade as a second,
independent readout for activation of Rac and Cdc42
(Coso et al., 1995; Minden et al., 1995; Tan et al., 1996),
and once again observed strong stimulation by agrin (Fig.
4 B, a). As shown by these assays, Rac/Cdc42 activation
Figure 2. Prevention of agrin-induced AChR clustering by dominant interfering mu-
tants of Rac (RacN17) and Cdc42 (Cdc42N17). C2C12 cultures were transfected with
T7 epitope–tagged RacN17, or Myc-tagged Cdc42N17. After 2 d in differentiation
medium, cultures were treated with agrin for 16 h and labeled with TMR-Bgt. (A) In
contrast to cells expressing vector (see Fig. 1), myotubes expressing RacN17 (a) do
not display clustered AChR after agrin treatment (b). Likewise, muscle cells trans-
fected with Cdc42N17 (c) do not show agrin-induced AChR clustering (d). Also visi-
ble in b and d are agrin-induced AChR clusters on nontransfected myotubes adjacent
to the transfected myotube. In contrast to RacN17- or Cdc42N17-transfected myo-
tubes, muscle cells expressing RasN17 (e) display AChR aggregates (arrows) upon
agrin treatment (f). Bar, 10 mm. (B) Quantitative comparison of AChR clusters on
the surface of transfected myotubes expressing RacN17 or Cdc42N17 versus control
myotubes (mean 6 SEM, n 5 40). 
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by agrin was not appreciable in undifferentiated C2C12
myoblasts (Fig. 4, A and B) or in HEK293 cells (Fig. 4
B), consistent with the selective expression in differenti-
ated muscle of MuSK, the putative receptor for agrin
(Valenzuela et al., 1996). Unlike agrin, anisomycin, an
activator of the JNK pathway (Hazzalin et al., 1996),
caused equivalent JNK activation in myoblasts and myo-
tubes (Fig. 4 B), showing that JNK itself is unaffected by
myotube differentiation. The possibility that agrin-
induced activation of JNK is mediated by MuSK is fur-
ther supported by the observation that JNK activation by
agrin was transient (Fig. 4 B), with a similar time course
as reported for other agrin-induced signals, such as the
stimulatory effect of agrin on AChR phosphorylation
(Ferns et al., 1996).
To ascertain that the stimulation of JNK by agrin did in-
deed reflect the activation of Rac or Cdc42 rather than
other upstream activators of JNK, a kinase assay using
transfected myotubes was used. Shown in Fig. 5 A are the
findings obtained with C2C12 cells that were transfected
with FLAG epitope–tagged JNK and, where indicated,
RacV12 or RacN17. Subsequently, JNK activation was
measured in the differentiated cultures with or without
pretreatment with agrin. In these experiments the exoge-
nously expressed JNK was immunoprecipitated with anti-
FLAG antibody and its activation was assayed by measur-
ing 
 
32
 
P-labeling of c-Jun in vitro
 
 
 
(Nimnual et al., 1998).
This approach allows measurement of JNK activation se-
lectively in transfected cells. As can be seen in Fig. 5 A,
when C2C12 cells transfected with JNK were treated with
agrin there was a sizeable increase in c-Jun phosphoryla-
tion. In contrast, agrin did not activate JNK in cells
cotransfected with the dominant negative RacN17. More-
over, in agrin-untreated myotubes expressing constitu-
tively active RacV12, JNK activation was higher than the
activation produced by agrin in cells expressing endoge-
nous Rac. These findings confirmed that the level of phos-
phorylated c-Jun monitored by these assays was a measure
of Rac activity, strengthening the conclusion that agrin in-
duces Rac activation in differentiated C2C12 muscle cells.
To determine the influence of Cdc42 on agrin-induced
JNK activation, measurements of JNK activation were
Figure 3. Stimulation of AChR cluster formation by constitutively ac-
tive mutants of Rac (RacV12) and Cdc42 (Cdc42V12). (A) The effect of
Rac and Cdc42 activation on AChR clustering was assessed by transfect-
ing cultures with T7-RacV12 (a and b) or myc-Cdc42V12 (c and d). Cells
were surface labeled with TMR-Bgt and immunolabeled with anti-T7 or
anti-myc antibody. Myotubes expressing RacV12 (a) showed markedly
elevated aggregation of surface AChR into microclusters (b). Myotubes
expressing Cdc42V12 (c) displayed a similar increase in AChR micro-
cluster formation (d). Bars, 10 mm. (B) Quantitative comparison of
AChR microcluster numbers on the surface of transfected myotubes ex-
pressing RacV12 or Cdc42V12 versus control myotubes (mean 6 SEM,
n 5 40). 
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carried out exactly as above using FLAG-tagged JNK-
transfected C2C12 muscle cultures, but in this case we
monitored the effects of coexpressing dominant nega-
tive Cdc42N17 or constitutively activated Cdc42V12. As
shown in Fig. 5 B, the Cdc42 mutants had parallel effects
to the analogous Rac mutants (Fig. 5 A). Thus, dominant
negative Cdc42 blocked agrin activation of JNK, as mea-
sured by the phosphorylation of c-Jun, whereas constitu-
tively activated Cdc42 produced markedly elevated c-Jun
phosphorylation. Together, these findings provide strong
evidence that agrin treatment of intact myotubes induces
activation of Rac and Cdc42, as measured by three inde-
pendent readouts.
 
Discussion
 
In this study we report that Rac and Cdc42 participate in
the signaling pathway by which agrin induces the cluster-
ing of surface AChR in differentiated muscle cells. This
conclusion is based on two lines of evidence. First, immu-
nofluorescence experiments with transfected myotubes
reveal that expression of dominant negative mutants of
Rac or Cdc42 abolished agrin-induced AChR clustering,
whereas the stimulation of this signaling pathway by con-
stitutively active mutants of either of these small G pro-
teins caused AChR to aggregate into microclusters inde-
pendently of agrin. Second, biochemical measurements
show that agrin produced marked activation of Rac and
Cdc42 specifically in differentiated myotubes. In contrast,
agrin had only minimal effects on Rac activity in undiffer-
entiated myoblasts and no detectable effect in nonmuscle
cells.
 
Activation by Agrin of Rac and Cdc42
 
The novel finding in this study that agrin activates Rac/
Cdc42 supports the notion that these Rho GTPases can
mediate the effects of agrin signaling on AChR clustering.
This activation was detected using three separate mea-
surements and was demonstrated both with endogenous
Rac in nontransfected muscle cultures and with ectopically
expressed Rac and Cdc42 in transfected myotubes.
 
 
 
The
most direct demonstration involved agrin-induced increases
in the selective binding of activated (GTP-bound) Rac and
Cdc42 to a Rac/Cdc42-binding domain (Sander et al.,
1998) derived from PAK, a downstream effector molecule
Figure 4. Stimulation of Rac and Cdc42 binding to PAK and
c-Jun phosphorylation by agrin treatment of C2C12 myotubes.
(A) Stimulation of Rac and Cdc42 binding to PAK. Agrin-induced
Rac activation (a) and Cdc42 activation (b) in nontransfected
C2C12 myoblasts and myotubes was measured by the increase in
the endogenous Rac or Cdc42 bound to PBD, a PAK1 domain
that specifically binds the GTP-bound form of Rac and Cdc42
(Sander et al., 1998). Cultures were treated with agrin, and lysates
were incubated with GST-PBD and Western blotted with anti-
body to Rac (a) or Cdc42 (b). Agrin caused increased association
of both Rac and Cdc42 with GST-PBD in myotubes but not in
myoblasts. (B) Muscle-selective activation of JNK by agrin treat-
ment. (a) Agrin-induced activation of JNK was determined in
myotubes, myoblasts, and HEK293 cells. JNK activation by agrin
was observed in differentiated C2C12 myotubes but not in undif-
ferentiated myoblasts or in HEK293 cells. Unlike agrin, anisomy-
cin, an activator of JNK by a distinct pathway, caused equivalent
JNK activation in myoblasts and myotubes, showing that JNK it-
self is unaffected by myotube differentiation. (b) Time course of
agrin stimulation of c-Jun phosphorylation in myotubes. The
transient nature of the response to the continued presence of
agrin is evidenced by the results showing that c-Jun phosphoryla-
tion reaches a maximum within 30 min and subsequently de-
clines.
Figure 5. Dependence of agrin stimulation of JNK activity on
Rac (A) and Cdc42 (B). C2C12 cells were cotransfected with
FLAG epitope–tagged JNK and Rac or Cdc42 mutants. Immu-
noprecipitated JNK was incubated with g-[32P]ATP and GST–
c-Jun. GST–c-Jun phosphorylation was visualized by autoradiog-
raphy. As quantitated by PhosphorImager, the three-fold in-
crease in phosphorylation induced by agrin was eliminated by
dominant negative Rac and Cdc42 mutants. Protein expression,
monitored by Western blotting with anti-JNK1, anti-T7, or anti-
myc antibodies, was equivalent under these conditions. 
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that is thought to link Rac activation to actin polymeriza-
tion (Manser et al., 1994; Arber et al., 1998; Sells et al.,
1999).
 
 
 
Additional evidence for agrin stimulation of Rac/
Cdc42 was obtained by recording the activation of a sec-
ond downstream component, JNK, and the conclusion
that JNK activation by agrin is indeed mediated by Rac
and Cdc42 was confirmed by showing that this activation
was blocked by overexpression of dominant negative mu-
tants of either G protein. It is noteworthy that the acti-
vation of JNK and the polymerization of actin by Rac
proteins are thought to occur through distinct effector
pathways (Joneson et al., 1996).
 
Rac and Cdc42 Mediate Agrin-induced Formation of 
AChR Clusters
 
Our findings that the dominant negative mutants RacN17
and Cdc42N17 block the induction by agrin of AChR clus-
tering suggest that Rac and Cdc42 activities are crucial for
this pathway. This interpretation is supported by the re-
sults of the converse experiments—that AChR on the sur-
face of myotubes transfected with the constitutively active
mutants RacV12 and Cdc42V12 underwent aggregation
without agrin treatment. However, under these conditions
AChR aggregated into microclusters significantly smaller
than the clusters induced by agrin treatment. This differ-
ence may reflect dissimilarity between the localized nature
of the signal when triggered by agrin at the cell surface
versus the more topologically diffuse signaling that arises
from overexpression of constitutively activated mediators
in the cytoplasm of transfected myotubes. Alternatively,
activation of Rac and Cdc42 may be sufficient for micro-
cluster formation but insufficient for the aggregation of
microclusters to form full-sized clusters. Thus, even if lo-
calized in nature, the elevation of Rac/Cdc42 activity may
be a necessary but not sufficient condition for the induc-
tion of fully developed clusters by agrin.
A decade after the discovery of agrin, the mechanism of
agrin-mediated AChR clustering is still unresolved, and
key players in both the agrin-signaling pathway and in the
structural interactions underlying AChR cluster formation
have yet to be identified. Until these findings, participa-
tion of only two components of this pathway, the receptor
tyrosine kinase MuSK and rapsyn, a linker protein associ-
ated with AChR, had been shown to be crucial on the ba-
sis of mouse knockout studies. It was observed that AChR
aggregation is absent at neuromuscular junctions in mice
deficient in either MuSK or rapsyn, and agrin does not in-
duce AChR clusters in cultured myotubes from mice lack-
ing MuSK or rapsyn (DeChiara et al., 1996; Apel et al.,
1997). In demonstrating that agrin-induced aggregation of
surface AChR is dependent on the activation of Rac and
Cdc42, our findings indicate that, like MuSK and rapsyn,
these monomeric G proteins are crucial components in
agrin-induced AChR clustering.
How might Rac and Cdc42 mediate the agrin-initiated
clustering of AChR and other constituents of the neuro-
muscular junction? The ability of activated Rac/Cdc42 to
induce reorganization of cortical actin by modulating the
dynamics of actin polymerization is now well documented
(for review see Hall, 1998). Moreover, surface AChR is
thought to be attached to the actin cytoskeleton via a com-
plex in which rapsyn links AChR to the actin-binding
protein utrophin, and recent findings indicate that agrin-
induced AChR aggregation involves the clustering of these
diffusely distributed complexes at sites of MuSK activa-
tion (Apel et al., 1995; Fuhrer et al., 1999). According to
our proposed scheme shown in Fig. 6, agrin-induced acti-
vation of Rac/Cdc42 produces highly localized reorganiza-
tion of cortical actin cytoskeleton, resulting in redistribu-
Figure 6. Model showing interactions
of surface AChR with associated pro-
teins and a suggested mechanism for
the Rac/Cdc42-mediated clustering of
these proteins in response to agrin. This
scheme is similar to that proposed by
Fuhrer et al., 1999. The novel feature is
the role of Rac and Cdc42 in inducing
the clustering by producing localized
remodeling of actin-based cytoskele-
ton upon the activation of these mono-
meric G proteins by agrin signaling.
Shown here is one possible mechanism
for Rac/Cdc42-mediated cytoskeletal
changes that involves the PAK, LIM ki-
nase cofilin downstream effector path-
way (Arber et al., 1998; Yang et al.,
1998; Sells et al., 1999). 
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tion of actin-anchored AChR-containing complexes into
clusters.
In conclusion, our findings implicate Rac and Cdc42 in
the coupling of signaling events initiated by the binding of
agrin to the aggregation of surface AChR at neuromuscu-
lar synapses. It is plausible that these Rho GTPases can
function to integrate multiple incoming signals to modu-
late AChR surface distribution. In addition to the agrin-
MuSK pathway, there is substantial evidence that AChR
clustering is regulated by other receptor tyrosine kinase
mediated pathways, such as BDNF acting through TrkB
receptors (Gonzalez et al., 1999), as well as by tyrosine
phosphatases (Dai and Peng, 1998). Thus, by means of lo-
calized changes in actin-based cytoskeleton, Rho GTPases
may serve to couple incoming signals from several phos-
phorylation pathways to AChR clustering at the neuro-
muscular junction.
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